Have you all forgotten . . .
that the company already has a COO, Frank Vazquez? I would assume his role is to relieve MS of many of the burdens of everyday management -- that's what COOs normally do, anyway. And he does have practical business experience: "Prior to joining CytoGenix, Mr. Vazquez was a consultant specializing in life science start-up enterprises. He was the founding President/CEO of Lark Technologies, Inc. and Medical Metrics, Inc. For the past 13 years, Mr. Vazquez has been engaged by BCMT, Inc. the commercialization subsidiary of Baylor College of Medicine, the University of Texas Health Science Center-Houston and individual clients to organize and start several new medical and biotechnology companies. Mr. Vazquez previously held management positions with CooperVision, Inc., Booz Allen and Hamilton, ITT Corporation and IBM."
Despite his presence, though, I don't see how anyone can view the current management team as anything other than mediocre (at best), based primarily on the performance / non-performance issues cited by CD, hogger, arnold, et al.